Ultragenyx Pharmaceutical

Aktienkurs
24.70
Täglich Wechseln
0.91 3.83%
Monatlich
2.07%
Jährlich
-45.53%
Q1 Prognose
23.94




Ebit Veränderung Datum
Acadia Pharmaceuticals USD 35.76M 3.38M 2025-09
Agios Pharmaceuticals USD -116.87M 10.19M 2025-09
Alnylam Pharmaceuticals USD -29.96M 34.85M 2025-09
BioMarin Pharmaceutical USD -31.69M 308.58M 2025-09
Insmed USD -261.35M 7.48M 2025-09
Ionis Pharmaceuticals USD -160.18M 304.96M 2025-09
Kyowa Hakko Kirin JPY 25.86B 13.04B 2025-09
MacroGenics USD 20.16M 55.51M 2025-09
Moderna USD -260M 557M 2025-09
Neurocrine Biosciences USD 239.3M 93.7M 2025-09
PTC Therapeutics USD 3.49M 38.35M 2025-09
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Sarepta Therapeutics USD -62.88M 178.46M 2025-09
Ultragenyx Pharmaceutical USD -170.89M 22.68M 2025-09
Vertex Pharmaceuticals USD 1.24B 84.6M 2025-09


Ultragenyx Pharmaceutical - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.